Key Highlights of the Screening
Target Group: Ideal for those aged 50+ experiencing memory concerns or with a clear family history.
Key Feature: Early detection of Alzheimer’s disease, even in the absence of symptoms.
Benefits: Evaluation of memory and cognitive function to enable timely and proactive care planning.
Screening Components: Memory assessment and testing of 4 essential biomarkers (p-tau217, GFAP, NFL, and Oligomerised amyloid beta).
Advanced Alzheimer’s Screening
Every memory is precious… Prioritise your brain health today.
Frequent forgetfulness, slower decision-making, confusion, or poor concentration can diminish the quality of life for both you and your family. These signs may not simply be “normal ageing” but rather warning signals of cognitive decline.
Suitable For:
Individuals aged 50+ who have noticed memory irregularities.
Those with a clear family history of Alzheimer’s or dementia.
Advantages of Early Screening:
Detect Alzheimer’s at the earliest stage, even before symptoms surface.
Comprehensive assessment of memory and cognitive performance.
Enables the development of a timely and effective care plan.
Examinations
Cognitive and Memory Assessment: Evaluation of brain performance.
p-tau217: Detects brain changes at the very earliest stages.
GFAP: A biomarker for brain cell inflammation.
NFL: A biomarker indicating brain cell degeneration.
Oligomerised amyloid beta: A critical indicator for Alzheimer’s pathology.
Do not wait for your memories to fade. Protect your brain today for a better quality of life in the future.
Request an Appointment
Advanced Alzheimer’s Screening
As this advanced screening requires a preliminary clinical evaluation by a specialist to ensure suitability, it is not available for direct purchase online.
Please provide your contact details below. A specialist nurse from the Neuroscience Centre will perform an initial symptom assessment and contact you to arrange a consultation with a physician.
All Neuroscience Packages

ไทย
简体中文




